Abstract | INTRODUCTION: [corrected] Hypoxia- ischemia (HI) injury in term infants develops with a delay during the recovery phase, opening up a therapeutic window after the insult. Hypothermia is currently an established neuroprotective treatment in newborns with neonatal encephalopathy (NE), saving one in nine infants from developing neurological deficits. Caspase-2 is an initiator caspase, a key enzyme in the route to destruction and, therefore, theoretically a potential target for a pharmaceutical strategy to prevent HI brain damage. METHODS: The aim of this study was to explore the neuroprotective efficacy of hypothermia in combination with caspase-2 gene deficiency using the neonatal Rice-Vannucci model of HI injury in mice. RESULTS: HI brain injury was moderately reduced in caspase-2(-/-) mice as compared with wild-type (WT) mice. Five hours of hypothermia (33 °C ) vs. normothermia (36 °C) directly after HI provided additive protection overall (temperature P = 0.0004, caspase-2 genotype P = 0.0029), in the hippocampus and thalamus, but not in other gray matter regions or white matter. Delayed hypothermia initiated 2 h after HI in combination with caspase-2 gene deficiency reduced injury in the hippocampus, but not in other brain areas. DISCUSSION:
|
Authors | Ylva Carlsson, Xiaoyang Wang, Leslie Schwendimann, Catherine I Rousset, Etienne Jacotot, Pierre Gressens, Marianne Thoresen, Carina Mallard, Henrik Hagberg |
Journal | Pediatric research
(Pediatr Res)
Vol. 71
Issue 5
Pg. 566-72
(May 2012)
ISSN: 1530-0447 [Electronic] United States |
PMID | 22322383
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Animals, Newborn
- Caspase 2
(genetics)
- Hypothermia, Induced
- Hypoxia-Ischemia, Brain
(prevention & control)
- Mice
- Mice, Knockout
|